News and Insights of 3D Printing and Manufacturing
CollPlant Biotechnologies released a letter from its Chief Executive Officer, Yehiel Tal, to its shareholders. The letter summarizes a strong year for the company and its shareholders, which has benefitted from the uptick in 3D printing research and interest throughout 2020 to position itself for an even stronger 2021. The letter reads as follows:
Researchers at the University of Stuttgart and Robert Bosch Hospital are developing a novel 3D printed tissue platform that could replace animal testing in clinical trials.
Last night, as I watched the latest episode of RuPaul’s Drag Race UK—the British spinoff of the long-running American reality TV competition that seeks to crown the next drag superstar—I was surprised and excited to hear the words 3D printing pop up.
Netherlands-based Luxexcel is a pioneer of 3D printed lenses. The company’s proprietary technology—first developed over a decade ago—stands on a strong foundation of optic, material, process and, of course, 3D printing expertise. Today, Luxexcel remains the only company to have developed a 3D printing process for creating prescription lenses.
Audio specialist Sennheiser’s AMBEO division is developing a production method that enables customers to affordably and easily customize their earphones to fit their unique ears. The custom-fit, 3D printed AMBEO ear tip prototypes in development further refine an immersive sound experience.
Researchers from the German Kiel University have developed novel 3D printed ‘spiky-joints’ that provide wrist injury patients with a more flexible form of arm support.
Pandorum Technologies Pvt., a Bangalore-based biotechnology company, has used 3D bioprinted cornea tissue to promote scarless healing of wounds in the eye.
HP, manufacturers of the award-winning Multi Jet Fusion (MJF) 3D printers, and SmileDirectClub, a Nashville-based teledentistry company, have announced a partnership to increase the production of its customized clear aligners at RAPID + TCT.
3D Printing Industry is in Detroit this week to bring our readers all the news from RAPID + TCT. So far we’ve published over 30 articles dedicated to the all the latest in the additive manufacturing ecosystem – with much more to come.
Canadian 3D bioprinting technology company Aspect Biosystems has announced its involvement in a $2.2 million project seeking to find new treatments for cancer. Starting this year, the company will be working with collaborators at two of the world’s largest pharmaceutical companies Merck and GSK, as well as McGill University’s Goodman Cancer Research Centre in Quebec.